Study of CM310 Injection in Adolescent Subjects With Atopic Dermatis

Clinical trial NCT06277765 · COMPLETED

Trial details

NCT number: NCT06277765
Sponsor: Keymed Biosciences Co.Ltd
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Atopic Dermatitis

Start date: 2024-03-21
Primary completion: 2025-01-23
Enrollment: 180

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.